USC Norris Westside Cancer Center

Beverly Hills, United States

···

Open now

Map

Streetview

Activate map

Description

Specialties

Keck Medicine of USC encompasses academic, research and clinical excellence, attracting over 500 of the finest internationally renowned doctors from across the world. It also includes more than 40 outpatient facilities, some at affiliated hospitals, in Los Angeles, Orange, Kern, Tulare and Ventura counties.

The USC Norris Westside Cancer Center offers the latest in treatments in cancer. The center is advancing the clinical care of cancer through novel clinical trials and by bringing new therapies to patients. In collaboration with the USC Center for Applied Molecular Medicine, we use the most current molecular technologies to help care for patients with cancer.

Our specialties include:

Dermatology

Primary Care

Ophthalmology

Orthopaedic SurgeryOtolaryngology — Head and Neck Surgery

Urology

Spine Center

Oncology

Ophthalmology Care

Prostate Cancer/​Urology Care, Dermatology

Pain Management

Cancer Treatment

Clinical Trials

Molecular Technology

History

Established in 1970.

1986: Professor emeritus Donald Skinner, former chair of the Catherine and Joseph Aresty Department of Urology, leads a team that improves bladder cancer surgical techniques, which allow patients to void naturally through their urethras.

1988: Brian Henderson, Distinguished Professor of Preventive Medicine and Neurology, discovers links between steroid hormones and prostate, breast and ovarian cancers. This breakthrough paved the way for new hormonal therapies, and revealed the protective benefits of the contraceptive pill against ovarian and endometrial cancer.

1991: First Annual Festival of Life held.

2008: Michael Lieber, professor of pathology, biochemistry and molecular biology, molecular microbiology and biological sciences, defines the key mechanisms for DNA changes in lymphoma.

2012: Peter Jones, distinguished professor of urology and biochemistry & molecular biology, and his research team identify specific genes that must be turned off in order for cancer cells to survive.